Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ovarian function following chemotherapy in young women with Non-Hodgkin lymphoma
ACTRN12610000785000Phase 2Terminated
- Sponsor
- Melbourne in vitro fertilization (IVF)
- Start
- Oct 2010
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of goserelin in ovarian hypofunction (POI) and ovarian dysfunction (2 arms), sponsored by Melbourne in vitro fertilization (IVF). Primary endpoints: Follicle stimulating hormone and Anti-mullerian hormone. Started Oct 2010; status: terminated.
02
Drugs
goserelin
03
Conditions
ovarian hypofunction (POI)ovarian dysfunction
Beyond the preview
Go deeper on ACTRN12610000785000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000785000.